TCGX Acquisition Corp. II

Last updated October 20, 2026

Organization details

Legal name
TCGX Acquisition Corp. II
Ownership
Public
Status
Active
Headquarters country
United States
Ticker symbol
TCXB
Primary stock exchange
Nasdaq

Identifiers

SEC CIK
0002149916

Board of directors

Chief executives

Chen-Ming Yu · Chief Executive Officer
Dates unknown

Board connections

3 of this board's directors also sit on 6 other boards.

Network of TCGX Acquisition Corp. II's board connections Spyre Therapeutics Inc. Spyre Therapeutics Inc... Amylyx Pharmaceuticals Inc. Amylyx Pharmaceuticals... BridgeBio Oncology Therapeutics Inc. BridgeBio Oncology The... Freenome Inc. Freenome Inc. Helix Acquisition Corp. III Helix Acquisition Corp... NewAmsterdam Pharma Company N.V. NewAmsterdam Pharma Co... Joshua B. Cohen Joshua B. Cohen Mark C. McKenna Mark C. McKenna Michael Thomas Henderson Michael Thomas Hende... TCGX Acquisition Corp. II
Shared director Other board Same sector

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Bought, last 12 months
$0
0 purchases by 0 insiders
Sold, last 12 months
$0
0 sales by 0 insiders
Date Insider Transaction Shares Price Value
Oct 19, 2026 Chen-Ming Yu Director, Officer (Chief Executive Officer) Grant or award +450,000 $10.00 $4,500,000

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.